RG-7882

N/A

Report date: 2024/02/05 13:54:07

Base Information

Drug NameRG-7882

Drug Alias NameD-4064ARG-7882DMUC-4064A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionMucin-16 inhibitors

TargetsMucin-16

Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[4]

Other Information

ATC CodeN/A